Tabrecta(capmatinib)

Metastatic NSCLC in adults whose tumors have a mutation leading to MET exon 14 skipping.

1 DTP program

From $2,650–$2,670/pack (56ct)

1 platform

FDA-Approved Indications

Metastatic NSCLC with METex14 skipping mutation

Available direct-to-patient (DTP) programs

Sorted by price, lowest first. Always verify eligibility and pricing directly with the manufacturer.

Lowest price option

via Novartis Direct · Novartis

$2,650–$2,670/pack (56ct)

77% off list price. 200mg 56ct: $2,649.92. 150mg 56ct: $2,669.52. Monthly cost ~double per-pack. Fulfilled through ASPN / Thrifty White.

Eligibility

Valid US prescription required. US residents only. HIPAA authorization required. Cell phone + text consent required for ASPN processing.

May purchase at cash price. Cannot seek reimbursement or count toward deductible.

Last verified: Mar 2026

Not sure which Tabrecta program fits your situation?